Every day we get tweeted by Elsevier about their wonderful #openaccess offerings. One of the latest pointed to: http://www.elsevier.com/about/open-access/open-access-journals. I chose http://www.journals.elsevier.com/applied-and-translational-genomics/ to see how this worked. Note licences are discussed under http://www.elsevier.com/journals/applied-and-translational-genomics/2212-0661/guide-for-authors where they offer CC-BY, CC-BY-NC-SA and CC-BY-NC-ND. So off to a paper:
At the bottom of the masthead is:
No apparent licence: © Copyright 2013 Elsevier B.V., All rights reserved.
No apparent licence: Copyright © 2013 Elsevier B.V. All rights reserved
(This one is 8 months ago so no excuse they “haven’t quite got round to it”).
No apparent licence: © Copyright 2012 Elsevier B.V., All rights reserved.
So very simply, Elsevier don’t seem care very much about honouring agreements they make with authors and/or they aren’t very competent at publishing. If you take 3000USD of someone and contract to apply one of three licences then you have a legal requirement to do so.
Let’s try a different journal: http://www.journals.elsevier.com/current-therapeutic-research/
And one of their featured articles
We’ll take 2:
Published this year, so after the journal was made Open Access. I scroll down and…
So in Elsevier’s new trumpeted Open Access journals, they not only take high APCs but also put the papers behind paywalls.
Oh, I spoke too soon:
CC-BY, but I have to pay to read it. And CC-BY with “All rights reserved”??
In some market sectors this would be criminal negligence, but because it’s scholarly publishing who cares that Elsevier is […]?